California Pharmacy Board Publishes Notice on Pharmacists Initiating and Administering Vaccines

By Sarah Dahm On October 8, 2021, the Board of Pharmacy (Board) published notice of its intent to amend section 1746.4 of Title 16, Division 17 of the California Code of Regulations (CCR) to permanently waive a requirement of pharmacists Continue reading

Board of Pharmacy Updates Ownership, Management, and Control of Pharmacy License Regulations

By Sarah Dahm On July 23, 2021, the California Board of Pharmacy (Board) issued notice of its proposed rulemaking action to amend section 1709, Title 16 of the California Code of Regulations (CCR). This proposed rulemaking action follows SB 1193 Continue reading

Board of Pharmacy Proposes Regulations to Add Self-Assessment Requirements for Third-Party Logistics Providers and Responsible Managers

By Sarah Dahm On September 17, 2021, the California Board of Pharmacy noticed its proposal to amend section 1784, Title 16 of the CCR to provide clarity with respect to whom the section applies, as third-party logistics providers (3PLs) perform Continue reading

Board’s Proposed Regulation Aims to Curtail the Ongoing Misuse and Abuse of Prescription Medication

By Steven Funk On September 17, 2021, the California Board of Pharmacy published notice of its intent to amend section 1715.65, Title 16 of the California Code of Regulations (CCR) to address frequent compliance questions the Board receives on the Continue reading

Board’s Proposed Amendment on Reporting Pharmacy Drug Loss Undergoing Review by OAL

By Steven Funk On June 4, 2021, the California Board of Pharmacy (BOP) published notice of its intent to amend section 1715.6, Title 16 of the CCR to reduce mandatory reporting of loss of controlled substances, which is set forth Continue reading

Medical Board of California Advises Licensees of New Prescribing and Reporting Rules for Controlled Substances Effective January 1, 2021

By Jonathan Padua On October 2, 2020, the Medical Board of California (MBC) issued a notice to its licensees reminding them about two new requirements, effective January 1, 2021, regarding prescribing and reporting on controlled substances. With respect to prescribing, Continue reading

Board of Pharmacy’s Community Pharmacy Staffing Regulation Takes Effect

By Anna Schwartz On September 15, 2020, OAL approved the Board of Pharmacy’s proposed regulations on community pharmacy staffing. The regulations add section 1714.3, Title 16 of the CCR to establish standards for community pharmacy staffing levels. The regulation implements Continue reading

Board of Pharmacy Readopts Emergency Regulation Related to HIV Preexposure and Postexposure Treatment

By Anna Schwartz At its September 17, 2020 meeting, the Board of Pharmacy (BOP) voted to readopt emergency regulations to add section 1747,  Title 16 of the California Code of Regulations (CCR) to establish a training program for pharmacists to Continue reading

Medical Board of California Endorses Legislation Allowing Pharmacists to Administer Potential COVID-19 Vaccines Without Federal-Level Approval

By Jonathan Padua At its August 13, 2020 meeting, the Medical Board of California (MBC), in anticipation of a potential COVID-19 vaccine becoming available to the general public, voted to support AB 1710 (Wood) (Chapter 123, September 24, 2020) a Continue reading